IA−Macrophages and Cytokine Networks Contribute to Tumor-Induced Suppression of CD4+Autoreactive T Cells
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Immunological Investigations
- Vol. 22 (3) , 169-187
- https://doi.org/10.3109/08820139309063401
Abstract
Tumor growth changes the functions and phenotypes of macrophages (M phi) and T cells. Suppression of CD4+ T cell autoresponses during tumor growth was contributed primarily by M phi. Tumor-induced alterations in the abilities of these cells to mediate autorecognition were assessed through syngeneic mixed lymphocyte reaction (SMLR) assays. Tumor-bearing host (TBH) M phi were significantly more suppressive (60-90%) than normal host (NH) M phi, and this suppression was caused partly by reduced Ia expression. TBH Ia- M phi were significantly more suppressive (50-80%) than their NH counterparts. The suppression mechanism was controlled partly by prostaglandin E2 (PGE2), because treating cultures with indomethacin and titrated NH and TBH Ia- M phi led to increased T-cell responsiveness, although responsiveness never reached levels of assays containing unseparated M phi. Blocking studies using anti-interferon-gamma (anti-IFN-gamma) monoclonal antibodies (mAb), anti-interleukin 4 (anti-IL-4) mAb, and indomethacin suggested that IFN-gamma, IL-4, and PGE2 contributed to tumor-induced M phi-mediated suppression. Our results suggested that a quantitative shift in M phi phenotype and a qualitative shift in M phi function in addition to differences in cytokine-directed accessory activities are partly responsible for tumor-induced suppression CD4+ T cell autoresponses.Keywords
This publication has 30 references indexed in Scilit:
- Tumor modulation of autoreactivity: Decreased macrophage and autoreactive T cell interactionsCellular Immunology, 1990
- Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cellsCancer Immunology, Immunotherapy, 1989
- Autologous mixed lymphocyte‐tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non‐specific killer T cells capable of lysing autologous tumorInternational Journal of Cancer, 1988
- Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.The Journal of Experimental Medicine, 1987
- Defects of Autologous Mixed Lymphocyte Reaction‐Activated Immunoregulatory T Cells in Patients with Systemic Lupus ErythematosusScandinavian Journal of Immunology, 1987
- Effect of prostaglandin E2 on the γ-interferon induction of antigen-presenting ability in P388D1 cells and on IL-2 production by T-cell hybridomasCellular Immunology, 1985
- Prostaglandins in inflammation and diseaseImmunology Today, 1984
- Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: An anomaly of increased production and decreased T-cell susceptibility during tumor growthCellular Immunology, 1984
- Autologous Mixed Lymphocyte Reaction in Patients with Hodgkin's DiseaseJournal of Clinical Investigation, 1980
- Poor Mixed Lymphocyte Reaction Stimulatory Capacity of Leukemic B Cells of Chronic Lymphocytic Leukemia Patients Despite the Presence of Ia AntigensJournal of Clinical Investigation, 1979